Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care

Clinical Nephrology

Volumn 58, Issue 3, 2002, Pages 238-243

  Russell, R ^a   Brookshire, M A ^a   Zekonis, M ^a   Moe, Sharon M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcific uremic arteriolopathy (CUA); Calciphylaxis; Hemodialysis; Phosphate binders; Phosphorus; Sevelemer hydrochloride (Renagel )

Indexed keywords

ALLOPURINOL; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CLONIDINE; DIPHENHYDRAMINE; ISOSORBIDE DINITRATE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; RECOMBINANT ERYTHROPOIETIN; SEVELAMER; SORBITOL; TERAZOSIN; WARFARIN;

AGED; ARTICLE; CALCIFIC UREMIC ARTERIOPATHY; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIET THERAPY; DISEASE SEVERITY; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MALE; PHOSPHATE BLOOD LEVEL; VASCULAR LESION; WOUND CARE; WOUND HEALING;

EID: 0036713078     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58238     Document Type: Article

References (38)

1. Systemic calciphylaxis revisited
2. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells
3. Calciphylaxis in patients on hemodialysis: A prevalence study
4. A case control study of proximal calciphylaxis
5. Calcific small vessel ischemic disease (calciphylaxis) in dialysis patients
6. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients
7. Bone morphogenetic protein expression in human atherosclerotic lesions
8. Calciphylaxis in chronic renal failure
9. Calcium-carbonate-induced calciphylaxis
10. The vascular lesions associated with skin necrosis in renal disease
11. Cutaneous necrosis from calcitic uremic arteriolopathy
12. Pathogenesis of calciphylaxis: Study of three cases with literature review
13. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis
14. Post-renal transplant calciphylaxis: Successful treatment with parathyroidectomy
15. Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure
16. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
17. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy
18. Calciphylaxis in three patients with end-stage renal disease
19. Calcified subcutaneous arterioles with infarcts of the subcutis and skin ("calciphylaxis") in chronic renal failure
20. Calciphylaxis and systemic calcinosis. Collective review
21. Spectrum of complications related to secondary hyperparathyroidism in a peritoneal dialysis patient
22. Calciphylaxis
23. Mathematical formulation to help identify the patient at risk of ischemic tissue necrosis - A potentially lethal complication of chronic renal failure
24. Calcific uremic arteriolopathy (calciphylaxis): An evolving entity?
25. Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consequences
26. Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy
27. Calcific uremic arteriolopathy in association with low turnover uremic bone disease
28. Risk factors and mortality associated with calciphylaxis in endstage renal disease
29. Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis
30. Dexamethasone enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells
31. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2
32. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression
33. Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapy
34. Sensitization to calciphylaxis by endogenous parathyroid hormone
35. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques
36. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification
37. Calcifying disorders of the skin
38. Calcium use increases risk of calciphylaxis: A case-control study